supply-chain disruption — e.g. “輝瑞大藥廠股份有限公司表示，因供應問題導致缺藥，目前無法預計恢復供應日期。” (Taiwan)
manufacturing problems — e.g. “Disruption of the manufacture of the drug.” (Canada)
raw-material (API) supply problems — e.g. “Shortage of an active ingredient.” (Canada)
Recent shortage history
Colombia: resolved 4 Jul 2026 (began 1 Apr 2025)
Colombia: resolved 22 Aug 2026 (began 4 Jan 2025)
Colombia: resolved 22 Aug 2026 (began 3 Aug 2023)
Colombia: resolved 4 Jul 2026 (began 8 Mar 2023)
Frequently asked questions
Is Quinapril currently in shortage?
Yes. As of the latest regulator updates, Quinapril has 7 active shortage notices across 2 countries (Canada, Taiwan). Status is refreshed daily from official regulatory sources.
Why is Quinapril in shortage?
Regulators attribute the current Quinapril shortages to supply-chain disruption, manufacturing problems, raw-material (API) supply problems. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Quinapril shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Quinapril status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.